Generics in the United Kingdom
Description
Generics>in>the>United>Kingdom
Summary
>Generics>in>the>United>Kingdom>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>size>(value>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
Summary
>Generics>in>the>United>Kingdom>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>size>(value>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
- A>generic>drug>is>defined>as>a>copy>of>an>ethical>(prescription)>drug>formerly>protected>by>patents>that>have>now>expired.>Both>unbranded>generics>and>branded>generics>are>included>in>our>market>scope.>However,>off-patent>drugs>that>continue>to>be>offered>by>the>original>manufacturer>under>the>original>name,>and>which>form>part>of>the>'generic-eligible'>market,>are>not>included.>Market>value>is>evaluated>at>ex-factory>prices.>Market>volume>refers>to>the>proportion>of>the>total>ethical>pharmaceutical>market>in>a>country>or>region>that>is>made>up>of>generic>drugs.>Thus,>it>is>a>measure>of>the>market>share>held>by>generics,>rather>than>a>direct>measure>of>the>total>market>volume.>Regional>volumes>are>calculated>as>averages>of>countries>that>comprise>the>region>where>volume>data>exists.
- The>UK>generics>market>recorded>revenues>of>$30.2>billion>in>2024,>representing>a>compound>annual>growth>rate>(CAGR)>of>7.7%>between>2019>and>2024.
- Market>consumption>volume>increased>with>a>CAGR>of>2%>between>2019>and>2024,>reaching>a>total>of>81.6%>of>total>pharma>volume>in>2024.
- In>2024,>the>revenue>of>the>UK>generics>market>experienced>an>annual>growth>of>8.9%.>The>market’s>growth>is>driven>by>the>rising>prevalence>of>chronic>diseases>such>as>diabetes,>hypertension,>and>cardiovascular>conditions,>increasing>the>demand>for>affordable,>long-term>medications.
- Save>time>carrying>out>entry-level>research>by>identifying>the>size,>growth,>major>segments,>and>leading>players>in>the>generics>market>in>the>United>Kingdom
- Use>the>Five>Forces>analysis>to>determine>the>competitive>intensity>and>therefore>attractiveness>of>the>generics>market>in>the>United>Kingdom
- Leading>company>profiles>reveal>details>of>key>generics>market>players’>global>operations>and>financial>performance
- Add>weight>to>presentations>and>pitches>by>understanding>the>future>growth>prospects>of>the>United>Kingdom>generics>market>with>five>year>forecasts
- What>was>the>size>of>the>United>Kingdom>generics>market>by>value>in>2024?
- What>will>be>the>size>of>the>United>Kingdom>generics>market>in>2029?
- What>factors>are>affecting>the>strength>of>competition>in>the>United>Kingdom>generics>market?
- How>has>the>market>performed>over>the>last>five>years?
- What>are>the>main>segments>that>make>up>the>United>Kingdom's>generics>market?
Table of Contents
46 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Hikma Pharmaceuticals Plc
- 8.2. Teva Pharmaceutical Industries Ltd
- 8.3. Novartis AG
- 8.4. Sun Pharmaceutical Industries Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: United Kingdom generics market value: $ million, 2019-24
- Table 2: United Kingdom generics market volume: % of total pharma volume, 2019-24
- Table 3: United Kingdom generics market geography segmentation: $ million, 2024
- Table 4: United Kingdom generics market value forecast: $ million, 2024-29
- Table 5: United Kingdom generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Hikma Pharmaceuticals Plc: Key Facts
- Table 7: Hikma Pharmaceuticals Plc: Annual Financial Ratios
- Table 8: Hikma Pharmaceuticals Plc: Key Employees
- Table 9: Teva Pharmaceutical Industries Ltd: Key Facts
- Table 10: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 11: Teva Pharmaceutical Industries Ltd: Key Employees
- Table 12: Novartis AG: Key Facts
- Table 13: Novartis AG: Annual Financial Ratios
- Table 14: Novartis AG: Key Employees
- Table 15: Sun Pharmaceutical Industries Ltd: Key Facts
- Table 16: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 17: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 18: United Kingdom Size of Population (Million), 2020-24
- Table 19: United Kingdom Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 20: United Kingdom GDP (Current Prices, $ Billion), 2020-24
- Table 21: United Kingdom Inflation, 2020-24
- Table 22: United Kingdom Consumer Price Index (Absolute), 2020-24
- Table 23: United Kingdom Exchange Rate, 2019-24
- List of Figures
- Figure 1: United Kingdom generics market value: $ million, 2019-24
- Figure 2: United Kingdom generics market volume: % of total pharma volume, 2019-24
- Figure 3: United Kingdom generics market geography segmentation: % share, by value, 2024
- Figure 4: United Kingdom generics market value forecast: $ million, 2024-29
- Figure 5: United Kingdom generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in the United Kingdom, 2024
- Figure 7: Drivers of buyer power in the generics market in the United Kingdom, 2024
- Figure 8: Drivers of supplier power in the generics market in the United Kingdom, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in the United Kingdom, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

